AstraZeneca: Bipolar Disorder trials
The registry lists 47 Bipolar Disorder studies with AstraZeneca as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 1Phase 3 16Phase 4 4No phase 26(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar DepressionCompletedNCT01256177Phase 3Results posted
- Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar DepressionCompletedNCT00926393Phase 4Results posted
- Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on TherapyCompletedNCT00857584Phase 3Results posted
- Pediatric Bipolar DepressionCompletedNCT00811473Phase 3Results posted
- Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar DisorderCompletedNCT00672490Phase 4Results posted
- Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.CompletedNCT00521365Phase 4Results posted
- Physician Survey on Monitoring of Patients Treated With QuetiapineCompletedNCT01795326
- EMR Data to Assess Monitoring of Patients Treated With QuetiapineCompletedNCT01793324
- Observation Study of the Clinical Management of Bipolar DisorderCompletedNCT01770704
- Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar DisorderTerminatedNCT01663974
- An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar DisorderCompletedNCT01455961
- General Practice Research Database Seroquel XR Safety StudyCompletedNCT01447082
- IBIS: Italian Burden of Illness on Schizophrenia & Bipolar DisorderCompletedNCT01392482
- The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription BehavioursCompletedNCT01377896
- PHARMO Institute Seroquel Safety StudyCompletedNCT01342120
- Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-upCompletedNCT01255982
- A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.CompletedNCT01202604
- Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451CompletedNCT01196676Phase 1
- Study of the Clinical Management of Bipolar DiseaseCompletedNCT01062607
- Management of Index Episode in Patients With Bipolar Disorder Treated by Seroquel XRCompletedNCT01029145
- Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionCompletedNCT01028196
- Nis Register Study Comparing Seroquel and Seroquel ProlongCompletedNCT00965536
- Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence StudyCompletedNCT00927420
- A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II DisorderCompletedNCT00888264
- Treatment Clinical Practice in Bipolar Depression in SpainCompletedNCT00757328
- Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic TreatmentCompletedNCT00692133
- Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood StabilizersCompletedNCT00691353
- Predictors of Recurrence in Bipolar Disorder in SpainCompletedNCT00690859
- Depressive Symptoms in Acute Manic EpisodeCompletedNCT00690248
- Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in TurkeyCompletedNCT00660712
- Effectiveness of Anti-Psychotic in GPs SettingCompletedNCT00543088
- A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)CompletedNCT00533260
- Quetiapine Efficacy in Bipolar Depression StudyCompletedNCT00523601
- FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute PsychosisTerminatedNCT00486798Phase 3
- Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder PatientsCompletedNCT00448578Phase 3
- Phase III/Seroquel SR Bipolar Depression Monotherapy - USCompletedNCT00422214Phase 3
- Phase 3 /Seroquel SR Acute Mania Monotherapy - USCompletedNCT00422123Phase 3
- Quetiapine Fumarate Bipolar Maintenance MonotherapyCompletedNCT00314184Phase 3
- Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid CyclingCompletedNCT00254774Phase 3
- Seroquel in Bipolar Depression Versus LithiumCompletedNCT00206141Phase 3
- Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic PatientsTerminatedNCT00139074Phase 4
- Seroquel in Bipolar Depression Versus SSRICompletedNCT00119652Phase 3
- Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCompletedNCT00107731Phase 3
- Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I ManiaCompletedNCT00090311Phase 3
- Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar DepressionCompletedNCT00083954Phase 3
- Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCompletedNCT00081380Phase 3
- Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar DepressionCompletedNCT00060489Phase 3